全部医药动态
全部动态
今日 35 条
CMSGov@CMSGovAI 评分2222
CMSGov@CMSGovAI 评分2222
PhRMA@PhRMAAI 评分1515
U.S. FDA@FDAAI 评分2020
هيئة الغذاء والدواء@Saudi_FDAAI 评分1818
NICE@NICECommsAI 评分2828
Damian Garde@damiangarde精选AI 评分6262推荐理由:英格兰将阿斯利康乳腺癌药物纳入报销,其定价与英美药品定价协议挂钩,可观察跨境定价谈判对市场准入的影响。
U.S. FDA@FDAAI 评分33
WHO/Europe@WHO_EuropeAI 评分88
CMSGov@CMSGovAI 评分33
هيئة الغذاء والدواء@Saudi_FDAAI 评分1818沙特食药监局(#الغذاء_والدواء)局长与多家新加坡公司举行圆桌会议;以支持投资合作途径。 https://sfda.gov.sa/ar/news/19516
U.S. FDA@FDAAI 评分1212
هيئة الغذاء والدواء@Saudi_FDAAI 评分2222沙特食药监局(#الغذاء_والدواء)与新加坡卫生科学局(HSA)签署谅解备忘录;以加强合作,支持监管与监督实践的发展并提升其效率。
هيئة الغذاء والدواء@Saudi_FDAAI 评分55
AEMPS@AEMPSGOBAI 评分3030
MHRAgovuk@MHRAgovukAI 评分1010这个#世界患者安全日,请知道你的经历很重要。 英国的患者可以直接向黄卡计划报告疑似药品和医疗器械的不良反应和问题 💛 ➡️ 了解更多:https://brnw.ch/21x5KQC
EU One Health@EU_HealthAI 评分88
NICE@NICEComms精选AI 评分6262推荐理由:NICE 将 Enhertu 纳入 NHS 常规使用,读者可据此了解 HER2-low 晚期乳腺癌的报销准入范围。
هيئة الغذاء والدواء@Saudi_FDAAI 评分2222沙特食药监局(SFDA)局长会见新加坡卫生科学局(HSA)局长,双方签署谅解备忘录,以加强在监管与规制领域的合作及经验交流。 https://sfda.gov.sa/ar/news/19512
FDA · 新闻稿AI 评分88 FDA 发布《FDA Food Code》食品法典
FDA 发布《FDA Food Code》食品法典。该文件为fda.gov发布的官方内容,具体条款与适用范围以原文为准。
FDA · 药品动态精选AI 评分7878 拜耳 Kerendia 获 FDA 批准,用于 1 型糖尿病相关肾病
拜耳 Kerendia 获 FDA 批准,用于 1 型糖尿病相关肾病,成为 30 年来该适应症的首个药物。该消息由 fiercepharma.com 报道。
FDA · 新闻稿AI 评分1111 FDA 发布《Food Code 2026》
FDA 发布《Food Code 2026》。该文件为食品行业监管提供最新规范依据。
Fierce Pharma精选AI 评分6767 FDA 批准 Ultragenyx 基因疗法 Fayuvi 用于罕见神经退行性疾病
FDA 批准 Ultragenyx 的基因疗法 Fayuvi,用于治疗一种罕见神经退行性疾病。该消息由 Fierce Pharma 报道,具体适应症与批准细节尚未在摘要中披露。
推荐理由:FDA 批准 Ultragenyx 基因疗法 Fayuvi 用于罕见神经退行性疾病,可了解该疗法的监管落地情况。
AEMPS@AEMPSGOB精选AI 评分4242西班牙药品和医疗器械管理局(AEMPS)公布人用药品委员会(CMH)2026年9月会议结果,列出该委员会给出积极意见的新药。CMH下次会议将于10月6日举行。
推荐理由:AEMPS公布人用药品委员会9月会议给出积极意见的新药名单,可了解西班牙新药审评的最新进展。
Vinay Prasad MD MPH@VPrasadMDMPHAI 评分00
The LancetAI 评分1515 《柳叶刀》评论:阿克拉重置须将主权转化为国家能力
《柳叶刀》评论指出,全球卫生传统治理架构正因资金流向剧变而严重受扰,低收入和中等收入国家受影响尤深。这些国家需协调全球卫生机构的外部投入,却对其授权、理事会、资金和激励缺乏控制权;卫生部对健康结果负责,外部伙伴却掌握优先事项、融资渠道、指标与数据的决定权。
The LancetAI 评分11 加强应对即将到来的超级厄尔尼诺的准备
新出现的厄尔尼诺事件的峰值预测显示,其月海表温度异常中位数预报可达+3.9°C,大幅超过2015–16年厄尔尼诺创下的+2.75°C最高纪录。厄尔尼诺是每2–7年发生一次的自然现象,但此次发生在人为气候变化背景下,可能随时间推移造成更极端的全球影响。
CDC@CDCgovAI 评分1818
Ashish K. Jha@ashishkjhaAI 评分1717请读一读我朋友 @kesvelt 的这篇长文。 关于AI赋能的生物武器以及制造它们有多难,有太多随意的讨论。 它们确实很难。 但低估这一威胁的后果是巨大的。非常巨大。
引用Kevin Esvelt@kesveltSome scientists argue civilization-threatening bioweapons are a fantasy. I wish they were correct, and that I've wasted years building defenses. That you can't see a way, or evidence that others can, doesn't mean no one could – especially if anyone cautious would stay silent. My ask to colleagues: please do not casually assert with confidence that nothing biological could bring down civilization, even on X. What we say can turn out to matter, especially when the Overton window on risk mitigation is wide open. When Fermi called the chain reaction a remote possibility, around 10%, Rabi replied that ten percent is not remote if it means we may die of it. And by then, Szilard had already begun reasoning about what to disclose, and when, and to whom, in order to best safeguard the future. I've been concerned that one of my human colleagues might notice one or more viable paths to pandemic weapons for over a decade. It's why I didn't publicly describe the categories of civilization-threatening pandemics and necessary defenses until 2023, but was starting to build cryptographic screening systems capable of controlling access to sequences without disclosing whether they're dangerous in 2018 – long before ChatGPT, and even before the debut of AlphaFold. AI can worsen biological risk, but biological risk hardly depends on AI. Who am I to weigh in on whether civilizational biothreats are possible? Fine, to get the expertise claims out of the way: yes, I specialize in evolutionary engineering, yes, I've worked with viruses with my own hands, and yes, I've worked quite extensively with AI, both LLMs and biodesign tools. I invented CRISPR-based gene drive, and held that back until confident it favored defense. While it hasn't yet been tested in the wild (due to politics), I haven't heard anyone suggest that it would suddenly stop working outside cage populations, so it might be fair to say I've (temporarily) beaten nature at its own game. I also was early to spot the full threat from mirror life and recruited others with more specialized expertise to evaluate it in depth; much to my disappointment, no one has yet struck a solid blow against that hypothesis. The reason why the threat from mirror life is public also explains why there isn't any similarly public evidence of other catastrophic biothreats. We communicated our reasoning on mirror life because no one can make mirror bacteria, we won't be able to do so for years, and many colleagues wanted to build it because they correctly noticed that doing so would be an awe-inspiring achievement... and weren't aware of the risk. As long as that was true, humanity would only drive closer to the cliff, which would be disastrous if said cliff exists. Crucially, pointing it out and urging a course correction while still far away meant that no one could use our findings as blueprints to send us careening over the edge. Contrast that with pandemic weapons, where any credible genomic blueprints for an accessible virus could be realized within weeks to months using synthetic DNA and existing reverse genetics protocols. Sure, any given design might fail; in bio, most project ideas do. But if you see enough potential shots on goal, your own historical success rate for ideas of comparable perceived difficulty may indicate that we have a serious problem. Even if every last design required extensive laboratory optimization, history demonstrates that there are people in the world who will perform that work; see the history of Biopreparat. Multiple nations still have bioweapon programs, and I would not assume that state actors aren't interested in pandemic-class weapons. Make it easy enough, and the Seiichi Endos of the world will be able to build them, too. Nor should we assume extensive optimization is required for every design; some charmed projects really do work out of the box, and if Murphy's Law were a thing, this would be one of them. The corollary is that if anyone thinks they know how to build a pandemic weapon that could bring down civilization, they'd damn well better keep it to themselves until we have defenses in place. Please, for the love of God, children, the future of humanity, or whatever you consider holy, let's err on the side of caution here. Because while we are already building defenses, they aren't yet ready. Untargeted metagenomic sequencing to detect Stealth pandemics, those that would otherwise infect most everyone before the first people started to die. Pandemic-proof PPE to defend against Wildfire pandemics, those with R0 8+ and CFR >50% – such PPE has to be trustworthy to the wearer, using the wearer's own senses, because I certainly wouldn't go out in a highly lethal measles-class pandemic for a measly paycheck pay unless I was exceptionally confident that I wouldn't be committing suicide and killing my family too. Far-UVC and triethylene glycol misters, installed liberally to the ACGIH limit and saturation respectively, will likely suffice to shut down most respiratory nucleic acid transmission between humans. That'll be crucial because I doubt enough people would take the warning of a Stealth pandemic seriously, since virtually no one would be in hospital, let alone dead. Shutting down the unnecessary transmission network is consequently our best bet, and incidentally a way to dramatically reduce human misery and chronic illness. Some might be confused why we cannot rely on vaccines against catastrophic biorisk. Briefly, they'll reliably fail against an adversary who can generate a thousand new immune-evasive potentially functional viral variants using a biodesign model good enough to succeed at least 0.1% of the time. Make them all, and let natural selection sort them out… or simply be cleverer than nature. We don't yet have such models, but many of my (well-meaning but security-naive) colleagues are trying, and no wonder, because the high-profile journals will publish such work. Like ways of increasing virulence, best we refrain from sharing such capabilities until effective defenses are in place. One can reasonably object that it'll be a long time until everyone in the world is protected; that the benefits will, at some point, outweigh the expected harms of misuse. I agree – just avoid doing anything that would threaten civilization itself until we have minimally adequate defenses in place. Being an optimist, I expect they'll arrive in less than a decade. The wonderful thing about biorisk, as opposed to AI alignment, is that we have a clearly actionable plan. If you haven't read "Delay, Detect, Defend" and "Securing Civilisation Against Catastrophic Pandemics", I encourage you to do so. Why is the issue of civilization-threatening bioweapons controversial now? Some of my friends seem particularly up in arms about biorisk being used to justify AI restrictions. Fair enough – if you don't see a way to do it, and you think AI broadly isn't as good as you are yet, it's understandable to infer that we don't yet have a problem. And it's simply true that people are dying of fixable problems as we speak. If we delay, some of those we might have saved will perish, and their deaths will be on our hands. We are just as responsible for the consequences of our inaction as the consequences of our actions. But if we're rash, far more people might die. Choosing the best course requires quantitative risk assessment, which in turn depends on our priors about the nature of reality. Folks may reasonably differ if civilizational collapse isn't on the table, but since that's what would likely happen given a Wildfire pandemic, I judge any nontrivial chance unacceptable – unless the alternative involves either extinction or an even greater chance of collapse. Others have asserted that everything is fine because DNA synthesis screening will prevent misuse. I'd love for that to be the case, but our currently employed defenses of the digital-to-physical bottleneck are woefully inadequate. Consider our publication earlier this year, in which we reported that 36 of 38 companies shipped pieces of the 1918 influenza genome. That was collectively enough to generate the virus using reverse genetics several times over – and they were ordered by a student using a pseudonym falsely claiming to work at an office address. No one asked whether we had permission to work with 1918 influenza (a select agent), or why we needed genes from it, even though the official U.S. guidance at the time instructed them to do so. In fairness to the companies, that guidance was voluntary, and the fragments we ordered were legal to produce and sell domestically in every nation of the world (export controls are complicated). That is still true today, which is why we have a problem. The upshot is that I would definitely not assume screening is a reliable defense. Virtually no detection systems can screen below 50 base pairs without an exploding false alarm rate. SecureDNA, the freely available cryptographic system I helped build, can readily do that and will also detect split-order attacks – but it isn't universally adopted, or even close. Meanwhile, molecular biology continues to advance. Two recent papers have reported new methods of assembling sub-50mer oligos that may be easier than old-fashioned polymerase chain assembly (PCA), underscoring the current magnitude of the (fixable) vulnerability. If you want bio to advance as quickly as possible, write to your relevant representative to demand DNA synthesis screening be effective as well as mandatory. If you haven't red-teamed a system, it's almost certainly full of holes. Honestly it's probably full of holes anyway, but at least the remainder will be harder to find. Since it's evidently possible to obtain whatever DNA you want, including 1918 influenza and smallpox, why is it that so many biologists seem resistant to the notion that biorisk is a serious problem? First, most don't know that it's possible to acquire the reagents. It's surprisingly inconsistent of our civilization to be so cautious with highly enriched fissile materials, yet so reckless with biological equivalents. But I suspect the more important reason is that most biologists, who spend their careers directly or indirectly fighting disease, are reluctant to believe that anyone would deliberately cause one. I agree that the risk of a deliberate pandemic in any given year is small. Even if there were credible public blueprints for pandemics (which thankfully haven't been available to date, which neatly explains why we haven't seen any deliberate ones), I expect there's only a 2% to 3% chance per year that someone would use them. I think that's unacceptably high, but others may reasonably disagree, as long as they're confident that the cost of precautionary measures would be too much of a burden on the rate of cures generated by AI-accelerated biotech. The calculation changes when we move from deliberate pandemics to civilization-threatening pandemic weapons: the latter definitely aren't worth risking. Which may be a clue as to why we disagree. I'm concerned about misuse because I'm an optimist with respect to the increasing power of technology to change the world. Since we can already do better than nature at optimizing for replication (with technologies like CRISPR-based gene drive), I'm exceedingly confident we can build more destructive weapons, because evolution isn't optimizing for that goal. Any harm to humans is either instrumental or incidental. @SGRodriques, who I'm singling out precisely because he's a friend, has argued that "We should not be talking about AI-engineered bioweapons like it is the literal end of the world." I agree entirely that we shouldn't be talking about how to build them. But to assert that they couldn't end the world seems a mite overconfident, especially when even blind nature has come up with nasty pathogens like myxoma virus. I suggest that one should not express confidence that something is impossible – or even 90% confidence – just because no (incredibly naive) researcher has yet shared any methods that seem plausible. That's especially true if some of your colleagues have devoted considerable time to mitigating risks that they evidently do perceive. Presumably they've either noticed something you haven't, or like Rabi, they've decided that 10% is not remote if it kills you. Sam notes that because evolution optimizes for replication, it'll quickly get rid of any virulence enhancements added to kill the host: "I guarantee you that machinery will disappear from the virus very quickly." In the long run he's correct, at least if those changes don't promote transmission (virulence and transmissibility aren't always opposed). But we don't care about the long run: as @baym noted in reply, it only needs to work for long enough. Engineered evolutionary stability is a thing we've frequently attempted in the lab. I'm afraid it's one of my specialties, and how long it will hold depends entirely on what is being stabilized and the replicator in question. Unfortunately, plugging laboratory data on empirical selection coefficients for engineered viruses into epidemiological models of pandemic spread clearly indicates that even costly virulence increases can hold for long enough. Now, I entirely agree with Sam and @DavidRBellamy that the discourse on AI-generated biological weapons is wildly off-base (kill switches are nonsense, and while I'm glad @AnnieJacobsen brought attention to the issue, I am not remotely concerned by any technical specifics of her biowarfare scenario). Yet I also think most biosecurity discourse is wildly off-base, even when other practicing biologists are an active part of the conversation. If you adopt the threat model of "traditional" biosecurity, or that of most virologists (insofar as they think about misuse), there's little reason for extreme concern. I strongly disagree. The traditional model naturally follows from the fact that we biologists study existing organisms, the ones illuminated by nature's streetlight. But we won't find the civilization-threatening keys under the streetlight, because evolution selects for replication, not harm. It would be surprising if there was much overlap between the patterns generated by two different optimization targets in hyperdimensional function space; I assert that there's almost none. That most scientists can't see any overtly destructive keys (or combinations of organisms they can see) is a very good thing, since we don't need those keys to cure disease, aging, and death. Unfortunately, they will become public knowledge eventually, because what we understand, we can build – and we intend to understand everything about how life and the universe work. Yet sequencing is everything, and not just for Stealth pandemic detection. It's just common sense to build defenses before you share knowledge of how to attack, especially if there's a chance that failing to defend will lose us the game. Curing disease requires an intact civilization, which is why humility favors caution. If AIs continue to improve, I assume they will eventually be better at science and engineering than I am, and have a better security mindset than even my cryptographer colleagues. It follows that they'll also be better at designing weapons. AI isn't there yet, but the writing's on the wall: an LLM has already disclosed a novel form of bioweapon that I hadn't realized was possible. This didn't require any special creativity, only knowing more about particular distinct subfields of biology than I did. It's entirely possible that no single human had all of the pieces, but once you have them, the way they fit together is obvious if you're thinking about misuse. If current LLMs can already teach me something novel in that category, why should we doubt that future models will be able to do even better? Each of us knows very little, even of the published literature. So much more is possible; I'm deeply envious (and hopeful, when it comes to beneficial research) that the models can internalize so much more. Given that LLMs are already capable of weapons-relevant insights that escape human experts, we should assume that future AIs will be able to build several different forms of civilization-threatening weapons, and to either disclose them or trick people into building them. That doesn't mean they'll choose to do so; AIs won't benefit from collapsing civilization as long as they depend on our supply chains. But models may be too shortsighted to appreciate that point, or too corrigible to care. Alignment looks hard enough that we could plausibly generate models that would share such knowledge for many different inscrutable reasons. In directed evolution, you get what you select for, which is not necessarily what you want. As Dan Selsam and others have eloquently laid out, the same is true of training AI. But let's be clear on the extent to which biological advances will likely follow from AI. This is an issue that aggravates my fellow biologists to no end, a reaction that's likely behind their frustration with AI safety discourse more generally. ASI will almost certainly not gain instant mastery of the world of atoms. Many AI safety folks casually claim that recursive self-improvement will produce an entity that has already mastered all of science – and therefore will be capable of designing and building weapons that could wipe out every human. Some even assert that Drexlerian nanotechnology will be accessible by thinking sufficiently hard, as though you can solve chemistry and biology and psychology from the Hamiltonian up. Yet I see no empirical or theoretical basis for assuming that experimental bottlenecks will disappear. Data is sharply limiting in biology. My lab found that when it comes to enzyme-focused biodesign models (ESM and similar), parameter size and optimization don't matter much until you have an awful lot of data matching genotype (DNA/protein sequence) to phenotype (performance of the molecular activity of interest). There's no doubt that ASIs will be able to design better experiments and get more out of the results than we could, but unless we think they can solve all of physics from the bottom up, I expect they'll still need data that we have not yet collected – which means they'll still have to run the experiments, analyze, and iterate. The world of atoms is hard, and slow, and we have to master it anyway. And ensure that defenses come first. Right now, it looks like they might not, in large part due to AI. The question, therefore, is what can be done that enough people might agree to support. My proposal on AI-bio: expand trusted-user programs conferring access to GPT-Rosalind and other cutting-edge bio-capable models (h/t @JonasSandbrink and BioTrust). Every legitimate researcher should be able to draw upon those models to help them with any question in their subfield, as defined by their publication record or that of their mentor. There should still be guardrails on other subfields, lest the model share novel combinatorial weapons with someone who might naively share them publicly, but we need to accelerate lifesaving research as fast as is safe. For reasons of politics, which regularly interferes with science, that probably means China needs to train their own closed-weight frontier bio-specializing model, and set up their own parallel trusted user program. This seems quite achievable without requiring any agreement on AI writ large. With scientists using frontier models, there will be no need for insecure open-weight models to answer questions on molecular and cellular biology. So let's ensure that future models aren't trained on any papers, patents, or textbooks describing details of molecular or cellular biology. Every developer does pre-training data curation; this is a straightforward extension. One can argue "what about medical providers?", at which point I must point out that physician-scientists will have trusted user access. Most other practitioners don't actually need LLM support for molecular and cellular biology, and if they do and somehow can't use a medical-only model, well, they too can get trusted-user access. Notably, supporting this proposal doesn't require one to accept loss-of-control risks from autonomous AI, or a need for pacing AI development; I'm curious to learn what @random_walker, @sayashk, and the other normal-technology folks think. In the long run, I confess that I doubt biological humans have the foresight, coordination, and wisdom to navigate every coming challenge ourselves, which may necessitate attempting ASI or something like it. Mirror life is the only publicly known, mechanistically concrete, civilization-threatening biothreat because it's both far away and we were going to make it by default. And while we seem to have been successful in persuading the scientific community that we shouldn't build it, I'm not remotely confident we'll be able to stop far enough short, because too many of my colleagues see no reason to forgo an otherwise useful technology – or even one that would simply be neat to demonstrate – simply because it would make it easier to build mirror bacteria. To paraphrase: "We've agreed no one will build the dangerous thing, so why not?" Well, Biopreparat is why not. Aum Shinrikyo is why not. Make it easy enough, and even the Unabomber is a good answer to "why not?" The same reasoning holds for any accessible weapon that could threaten civilization. As Rabi said, ten percent is not remote if we die of it. Our own reality turned out to be in that 10%, and many died of it. That the rest of us are here today is in large part due to Szilard, Einstein, Rabi, and many others who saw the risk coming and took precautions. The least we can do is follow in their footsteps. — AI use disclosure: I ran this by Fable (triggering a classifier), Opus (classifier), Astra (extra scrutiny), and Kimi K3 (open weights = reliable jailbreaking with no enforced patches, which highlights the problem, because this topic does warrant extra scrutiny). All errors and misinterpretations are entirely mine. Links for the patient and deeply interested: Dan Selsam's eloquent thoughts on AI alignment: https://x.com/DKokotajlo/status/2099600298855829616 I'm grateful that practitioners of directed evolution don't have to deal with cheater molecules that are situationally aware enough to infer the goal of our selection and fake results so they pass… David Bellamy's critique of the risk delta from AI, particularly on its own: https://x.com/DavidRBellamy/status/2099187370407112758 Sam Rodriques echoes David, and Michael Baym pushes back on evolutionary stability: https://x.com/SGRodriques/status/2099641048192725387 Our report on the failures of gene synthesis screening (credit to Rey Edison and Shay Toner, who did the work – sure would be lovely if HHS would update the select agent program): https://www.nature.com/articles/s41467-025-67955-3 Effective and privacy-preserving gene synthesis screening: https://securedna.org/ https://www.biorxiv.org/content/10.1101/2024.03.20.585782v2 https://academic.oup.com/nsr/article/13/14/nwag103/8487636 New methods of assembling sub-50bp oligos (add them to PCA and Golden Gate): https://www.nature.com/articles/s41586-025-10006-0 https://www.nature.com/articles/s41587-026-03266-2 An example of a model that, once sufficiently effective at predicting which combinations of mutations in major antigenic sites will escape population immunity while retaining function, will ensure that vaccines are ineffective against competent adversaries with access to the model: https://www.nature.com/articles/s41586-023-06617-0 "Delay, Detect, Defend" – my own published roadmap to victory over pandemic weapons: https://www.gcsp.ch/publications/delay-detect-defend-preparing-future-which-thousands-can-release-new-pandemics "Securing Civilisation Against Catastrophic Pandemics": https://www.gcsp.ch/publications/securing-civilisation-against-catastrophic-pandemics Far-UVC and triethylene glycol efficacy and safety: https://www.nature.com/articles/s41598-024-57441-z https://pubmed.ncbi.nlm.nih.gov/41575207/ https://pubmed.ncbi.nlm.nih.gov/37929787/ SecureBio Detection, for early warning of Stealth pandemics (which recently received a generous $17M gift from the OpenAI Foundation): https://securebio.org/detection/ My Substack, which may provoke inspiration or nightmares depending on your temperament: https://kesvelt.substack.com/
FiercePharma@FiercePharmaAI 评分4242
U.S. FDA@FDAAI 评分1212
NICE@NICEComms精选AI 评分6060
推荐理由:NICE 最终指南将 mirdametinib 纳入特定儿童神经肿瘤人群,可了解其适用条件与受益规模。
Roche@RocheAI 评分1212
CMSGov@CMSGovAI 评分1818
ANSM@ansm精选AI 评分4242法国药监机构ANSM表示,用于预防婴儿VRS感染(毛细支气管炎)的预防性治疗药物安全性已得到确认,但再次收到用药错误报告。ANSM在公告中提示公众查阅全部相关信息,详情见其提供的链接。
推荐理由:法国药监确认婴儿RSV预防用药安全性,同时提示再次出现用药错误,可供关注儿科用药风险者参考。
Gilead Sciences@GileadSciences精选AI 评分4747吉利德宣布扩大其六项免专利许可协议的范围,这些协议原本覆盖其一年两次给药的HIV预防药物,现新增一项在研的一年一次给药剂型。公司未披露协议涉及的具体企业及在研剂型的临床阶段。

推荐理由:原文披露了授权协议范围扩展至在研一年一次剂型,可据此观察长效HIV预防的可及性布局。
AEMPS@AEMPSGOB精选AI 评分4040西班牙药监机构 AEMPS 发布提醒,说明如何避免因维生素D过量导致的用药差错。AEMPS 表示,仍在收到因骨化二醇或胆钙化醇类药物在处方、调配或给药环节出错而引发严重高钙血症的病例报告。
推荐理由:AEMPS 通报维生素D制剂处方、调配与给药环节的过量用药问题,可了解相关用药差错的防范要点。
هيئة الغذاء والدواء@Saudi_FDAAI 评分1818沙特食药监局局长在医疗器械监管机构国际论坛(IMDRF)第三十届年度会议上表示: 在沙特……我们将创新转化为安全、有效、可应用和可扩展的解决方案。
FDA · 食品安全召回AI 评分2222 FDA 因细菌风险召回佐治亚州销售的手部香皂
FDA 因细菌风险召回在佐治亚州销售的手部香皂。
FDA · 食品安全召回AI 评分3838 FDA 警告召回洗手液可能含有害细菌
FDA 警告一批被召回的洗手液可能含有有害细菌。相关产品已启动召回,FDA 提醒消费者注意这一潜在风险。